Top stories

The Big Read

Business

EQT Agreed to Buy Cleanaway for A$3.095 a Share, a A$9.3 Billion Deal. Three Days Earlier, the Stock Fell 7.6 Per Cent and the ASX Asked Why.

The price is 3.5 cents below the August proposal because a dividend has since been paid, and the premium the company quotes is measured against the old figure. The more telling number is the share price on the Friday before signing.

An aerial view of a landfill, with a compactor driving across a broad layer of mixed household waste and bare earth beyond.

A compactor spreads waste at a landfill in Calgary, Alberta. The site is not one of Cleanaway's. File photograph.

EQT Infrastructure has agreed to buy Cleanaway Waste Management, the Australian waste collector and landfill operator, for A$3.095 a share in cash, a deal Cleanaway says values the business at about A$9.3 billion including debt.

Cleanaway told the ASX on Monday 19 October, Sydney time, that it had signed a binding scheme implementation deed with Sedum Group Pty Ltd, an entity owned by funds managed or advised by EQT. The price is settled. The interesting part is what happened to the shares three days before it was.

Shareholders are to receive A$3.095 in cash for each share, less the cash amount of any dividends paid before the deal completes. That is 3.5 cents below the A$3.13 that EQT proposed in August, because Cleanaway paid a FY26 final dividend of 3.5 cents a share on 8 October, the release said.

Continue reading …

Opinion

What’s News

More News
Got a tip for us?

Editors read every submission. Here is how to send documents, on background or on the record.

How to submit

The Picture

Silhouette of an oil refinery and cooling towers across an estuary at sunset, with tidal flats in the foreground.
A refinery at dusk. Producer prices for gasoline rose 20.3 per cent in September, the Bureau of Labor Statistics said. File photograph.

Wholesale Prices Rose 1.3 Per Cent in One Month, the Most Since 2022, and Are Up 6.3 Per Cent in a Year. Retail Gasoline Margins Fell 30.3 Per Cent.

Editor's Choice

Latest News

Everything we have published, newest first

World

EU Leaders Pressed Brussels for Quotas on Chinese Chemicals and Machinery. The Hybrid-Car Deal Covers €15 Billion of a €360 Billion Deficit.

At their Brussels summit on 15 October, EU leaders pushed for import quotas to protect chemicals and industrial machinery from Chinese competition, Euronews reports, and a senior EU official said the Commission will present two new trade tools by the end of the year. The bloc's annual trade deficit with China is a record €360 billion.

By Thomas Gutierrez  

Stainless-steel pipes, valves and steel framing inside an industrial plant, in black and white.

Technology

Thoma Bravo's Proofpoint Will Pay $6.3 Billion in Cash for Varonis at $49.75 a Share. The Premium Is 52 Per Cent Against June and 17 Per Cent Against September.

Proofpoint, a Thoma Bravo portfolio company, agreed on Thursday 15 October to buy Varonis Systems for $49.75 a share in cash, a deal valued at about $6.3 billion. Varonis would owe a $211.7 million termination fee in some cases; Proofpoint would owe $423.3 million in others. Closing is expected in the first half of 2027 and needs a Varonis shareholder vote and regulatory approvals.

By Alison Acosta  

Yellow fibre-optic patch cables plugged into rows of green connectors in a network cabinet.
Business

McKesson Is Paying $1.4 Billion for Half of Option Care. The Deal Sets Up a Framework for It to Buy the Rest.

Clayton Dubilier & Rice and McKesson agreed on Monday to take Option Care Health, the largest independent home infusion company in the United States, private for $32.05 a share. McKesson is putting in about $1.4 billion for 49 per cent, and the agreement sets out a framework for it to buy the private equity firm's majority later. Lenders have committed more money to the deal than the two buyers have.

A bag of blood with a drip chamber and tubing hanging from a stand in a clinical setting.
Insulators, switchgear and overhead lines at an electric power substation under a pale sky.
The Numbers

Industrial Production Rose 0.7 Per Cent in September, and Utilities Supplied More of It Than Factories. Manufacturing Rose 0.3 Per Cent and Is Up 1.1 Per Cent in a Year.

The Federal Reserve said on Friday 16 October that industrial production rose 0.7 per cent in September after a 0.1 per cent gain in August. Utilities output rose 3.5 per cent, manufacturing 0.3 per cent and mining 0.2 per cent. Capacity utilization rose to 76.9 per cent, 2.5 points below its long-run average.

By Daniel Okafor  

Health

One Research Firm Puts Regenerative Medicine at $41 Billion, Heading for $162 Billion. Dr. David Borenstein on Why the FDA Keeps Cracking Down on Unproven Clinics.

DelveInsight, a market-research firm, estimates the global regenerative medicine market at about $41 billion in 2025 and projects roughly $162 billion by 2034. The FDA has spent years pursuing clinics selling unapproved stem cell products, most recently in a January 2025 warning letter to a Pompano Beach, Florida manufacturer. Dr. David Borenstein, a physician who offers regenerative treatments, says patients should ask what a product is before they book.

By Thomas Gutierrez  

A culture growing on agar in a petri dish, lit from below in a laboratory.
Health

Labcorp Will Pay $722 Million in Cash for the Core of BioReference Health, About 2.9 Times the Revenue It Expects. OPKO Gets Up to $150 Million More if One Prostate Test Sells.

Labcorp said on Thursday 15 October that it will buy select assets of BioReference Health from OPKO Health for $722 million in cash at closing, plus up to $150 million tied to revenue from the 4Kscore prostate test. Labcorp expects the businesses to bring in about $250 million in revenue in the first year after closing. The deal needs regulatory approval and has no stated closing date.

By Thomas Gutierrez  

What We’re Following

View all

Technology

Japan Will Pay Up to $21 Billion for Two New Fabs in Upstate New York. GlobalFoundries Will Run Them, and Washington Will Own About 4 Per Cent of the Company.

GlobalFoundries said on Wednesday 14 October that it will be the technology provider and operator for two new chip plants at its Malta, New York site, funded by up to $21 billion from Japan under the U.S.-Japan trade agreement. The first fab is expected to come online in 2029. In a separate agreement, the Commerce Department will take about 4 per cent of the company.

By Alison Acosta  

Two patterned silicon wafers on display, catching coloured light.
More Stories

Opinion Voices

Argument and analysis from our columnists

Featured Voices

The reporters and editors behind the coverage

The Story So Far

The Hormuz Closure28 stories

The Cranberry Brief

Reporting on business, technology and power, each weekday morning.

We’ll only use your address to send The Cranberry Brief. Unsubscribe anytime. Read our privacy policy.